Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

CinnoVex home page
Arginase-1 is expressed exclusively by infiltrating myeloid cells in CNS injury and disease.
BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients
12-oxo-phytodienoic acid, a plant-derived oxylipin, attenuates lipopolysaccharide-induced inflammation in microglia.
Fumaric acid esters prevent the NLRP3 inflammasome-mediated and ATP-triggered pyroptosis of differentiated THP-1 cells.
Association Between Sleep Problems and Perceived Cognitive Dysfunction Over 12 Months in Individuals with Multiple Sclerosis.
Annual incidence, prevalence, and mortality of multiple sclerosis in white South-African-born and in white immigrants to South Africa.
Hydrogen-rich water improves neurological functional recovery in experimental autoimmune encephalomyelitis mice.
Ncx3 gene ablation impairs oligodendrocyte precursor response and increases susceptibility to experimental autoimmune encephalomyelitis.
A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis.
Fumaric acid esters promote neuronal survival upon ischemic stress through activation of the Nrf2 but not HIF-1 signaling pathway.
Episode 25 with actor and science advocate Alan Alda discussing communicating science
Akt Regulates Axon Wrapping and Myelin Sheath Thickness in the PNS.
Synthesis of novel therapeutic agents for the treatment of multiple sclerosis: A brief overview.
Alemtuzumab vs. interferon beta-1a in early multiple sclerosis.
The role of global and regional gray matter volume decrease in multiple sclerosis.
Susceptibility tensor imaging (STI) of the brain.
Effect of disease-modifying drugs on cortical lesions and atrophy in relapsing-remitting multiple sclerosis.
An Exploratory Investigation of Social Stigma and Concealment in Patients with Multiple Sclerosis.
Full Prescribing Information, Copaxone (glatiramer acetate)
Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: a 52-week phase II trial.
10% liquid human immunoglobulin (KIOVIG(®)) for immunomodulation in autoimmune disorders.
Episode 11 with Dr. Jack Antel on remyelination and on bedside-to-bench research
The "poison chair" treatment for multiple sclerosis.
Is the MS community ready to promote brain health? Reception and Symposium

Pages